K

K2 Therapeutics

K2 Therapeutics is a Singapore-based biotech company focused on developing innovative therapies. The company has recently secured a significant seed funding round to advance its research and development efforts. This funding will support their mission to create impactful solutions in the healthcare sector.

Total raised
$50M
tracked to date
Latest round
Seed
Aug 11, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Singapore.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 Singapore Funding Report

Read the Q3 2026 Singapore report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-singapore-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Singapore Funding Report</a>

Funding history

  1. 1
    $50MSeedAug 11, 2026
    Announcement ↗

Founder

H
Huang Ying
CEO

K2 Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile

K2 Therapeutics — Health startup in Singapore | Datapile